| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |